Ocugen Inc (OCGN)
0.9203
-0.05
(-5.51%)
USD |
NASDAQ |
Oct 31, 16:00
0.9244
0.00 (0.00%)
After-Hours: 20:00
Ocugen Cash from Operations (TTM): -45.51M for June 30, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
June 30, 2024 | -45.51M |
March 31, 2024 | -54.41M |
December 31, 2023 | -62.05M |
September 30, 2023 | -67.67M |
June 30, 2023 | -68.26M |
March 31, 2023 | -63.25M |
December 31, 2022 | -60.08M |
September 30, 2022 | -55.97M |
June 30, 2022 | -49.72M |
March 31, 2022 | -57.72M |
December 31, 2021 | -47.94M |
September 30, 2021 | -39.42M |
June 30, 2021 | -34.02M |
March 31, 2021 | -15.31M |
December 31, 2020 | -14.71M |
September 30, 2020 | -19.17M |
June 30, 2020 | -13.12M |
March 31, 2020 | -13.09M |
December 31, 2019 | -16.89M |
September 30, 2019 | -15.09M |
Date | Value |
---|---|
June 30, 2019 | -25.40M |
March 31, 2019 | -27.56M |
December 31, 2018 | -15.78M |
September 30, 2018 | -13.16M |
June 30, 2018 | -11.97M |
March 31, 2018 | -12.39M |
December 31, 2017 | -23.02M |
September 30, 2017 | -24.59M |
June 30, 2017 | -24.33M |
March 31, 2017 | -25.24M |
December 31, 2016 | -25.74M |
September 30, 2016 | -26.84M |
June 30, 2016 | -28.26M |
March 31, 2016 | -29.19M |
December 31, 2015 | -30.03M |
September 30, 2015 | -27.72M |
June 30, 2015 | -23.63M |
March 31, 2015 | -21.61M |
December 31, 2014 | -17.94M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-68.26M
Minimum
Jun 2023
-13.09M
Maximum
Mar 2020
-42.02M
Average
-47.94M
Median
Dec 2021
Cash from Operations (TTM) Benchmarks
Cytokinetics Inc | -399.06M |
Scholar Rock Holding Corp | -168.60M |
Mirum Pharmaceuticals Inc | -23.43M |
SpringWorks Therapeutics Inc | -233.89M |
NeuroBo Pharmaceuticals Inc | -19.90M |